Unilever won't up £50 bn offer for GSK-Pfizer unit
-
'Amazing' feeling for Rees-Zammit on Wales return after NFL adventure
-
'Cruel' police raids help, not hinder, Rio's criminal gangs: expert
-
S. African president eyes better US tariff deal 'soon'
-
Sinner cruises in Paris Masters opener, Zverev keeps title defence alive
-
Winter Olympics - 100 days to go to 'unforgettable Games'
-
Kiwi Plumtree to step down as Sharks head coach
-
France to charge Louvre heist suspects with theft and conspiracy
-
US media mogul John Malone to step down as head of business empire
-
'Never been this bad': Jamaica surveys ruins in hurricane's wake
-
France adopts consent-based rape law
-
Zverev survives scare to kickstart Paris Masters title defence
-
Rabat to host 2026 African World Cup play-offs
-
Wolvaardt-inspired South Africa crush England to reach Women's World Cup final
-
US says not withdrawing from Europe after troops cut
-
WHO urges Sudan ceasefire after alleged massacres in El-Fasher
-
Under-fire UK govt deports migrant sex offender with £500
-
AI chip giant Nvidia becomes world's first $5 trillion company
-
Arsenal depth fuels Saka's belief in Premier League title charge
-
Startup Character.AI to ban direct chat for minors after teen suicide
-
132 killed in massive Rio police crackdown on gang: public defender
-
Pedri joins growing Barcelona sickbay
-
Zambia and former Chelsea manager Grant part ways
-
Russia sends teen who performed anti-war songs back to jail
-
Caribbean reels from hurricane as homes, streets destroyed
-
Boeing reports $5.4-bn loss on large hit from 777X aircraft delays
-
Real Madrid's Vinicius says sorry for Clasico substitution huff
-
Dutch vote in snap election seen as test for Europe's far-right
-
Jihadist fuel blockade makes daily life a struggle for Bamako residents
-
De Bruyne goes under the knife for hamstring injury
-
Wolvaardt's 169 fires South Africa to 319-7 in World Cup semis
-
EU seeks 'urgent solutions' with China over chipmaker Nexperia
-
Paris prosecutor promises update in Louvre heist probe
-
Funds for climate adaptation 'lifeline' far off track: UN
-
Record Vietnam rains kill seven and flood 100,000 homes
-
Markets extend record run as trade dominates
-
Sudan govt accuses RSF of attacking mosques in El-Fasher takeover
-
Rain washes out 1st Australia-India T20 match
-
Spain's Santander bank posts record profit
-
FIA taken to court to block Ben Sulayem's uncontested candidacy
-
Chemicals firm BASF urges EU to cut red tape as profit dips
-
Romania says US will cut some troops in Europe
-
Israel hits dozens of targets as Gaza sees deadliest night since truce
-
Mercedes-Benz reassures on Nexperia chips as profit plunges
-
France tries Bulgarians over defacing memorial in Russia-linked case
-
BBC says journalist questioned and blocked from leaving Vietnam
-
UK drugmaker GSK lifts 2025 guidance despite US tariffs
-
Mercedes-Benz profit plunges on China slump and US tariffs
-
South Korea gifts Trump replica of ancient golden crown
-
Record Vietnam rains kill four and flood 100,000 homes
-
Norway's energy giant Equinor falls into loss
NYSE - LSE
| CMSD | -0.28% | 24.57 | $ | |
| JRI | -1.59% | 13.83 | $ | |
| BCC | -2.74% | 70.44 | $ | |
| CMSC | 0.28% | 24.327 | $ | |
| RIO | 0.83% | 72.59 | $ | |
| SCS | -3.96% | 16.045 | $ | |
| NGG | -1.28% | 75.68 | $ | |
| RYCEF | -0.65% | 15.36 | $ | |
| RBGPF | -0.11% | 79 | $ | |
| BTI | -1.44% | 51.715 | $ | |
| AZN | -0.79% | 81.96 | $ | |
| BP | 2.27% | 35.26 | $ | |
| GSK | 4.9% | 45.95 | $ | |
| BCE | -0.62% | 23.425 | $ | |
| RELX | -3.31% | 44.75 | $ | |
| VOD | -2.86% | 11.895 | $ |
Unilever won't up £50 bn offer for GSK-Pfizer unit
Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.
British group GSK at the weekend said it had received three unsolicited offers from Unilever for GSK Consumer Healthcare -- all of which were rejected for being too low.
US company Pfizer owns a minority stake in the unit.
"Unilever is committed to maintaining strict financial discipline to ensure that acquisitions create value for our shareholders," it said in a statement Wednesday, adding that it would not raise the offer above £50 billion ($68 billion).
British company Unilever on Monday said its "future strategic direction lies in materially expanding its presence in health, beauty and hygiene".
GSK Consumer Healthcare's leading products include Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu.
Unilever's major offerings include Magnum ice cream, Cif surface cleaner and Dove soap.
"Unilever... reiterates its commitment to continuing to improve the performance of its existing portfolio through its ongoing focus on operational excellence, its upcoming reorganisation and by rotating the portfolio to higher growth categories," it added Wednesday.
Unilever recently agreed to sell its global tea business, including brands Lipton and PG Tips, for 4.5 billion euros to private equity group CVC Capital Partners.
Ahead of Unilever appearing to have closed the door on the healthcare unit, analysts said private equity groups would likely be interested in bidding for GSK Consumer Healthcare.
Unilever's last bid in December comprised £41.7 billion in cash and £8.3 billion in Unilever shares.
The offers came as GSK was looking to spin off the consumer health division to concentrate on its main pharmaceutical arm.
GSK is led by Emma Walmsley, one of only eight women chief executives running companies on London's benchmark FTSE 100 index.
Walmsley, who headed the GSK consumer unit before its merger with Pfizer and her promotion to GlaxoSmithKline CEO, has faced severe shareholder pressure over her company's delays in producing Covid jabs and treatments.
The consumer healthcare business meanwhile had annual sales of £9.6 billion last year.
GSK owns a majority 68 percent of the unit with Pfizer the remainder.
E.Qaddoumi--SF-PST